Advanced search
Publication Cover
Bioengineered Volume 14, 2023 - Issue 1
Submit an article Journal homepage
873
Views
0
CrossRef citations to date
0
Altmetric
Research Article

GXMR-CAR containing distinct GXM-specific single-chain variable fragment (scFv) mediated the cell activation against Cryptococcus spp. And had difference in the strength of tonic signaling

Michele Procópio Machadoa Department of Cellular and Molecular Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao, Sao Paulo, BrazilView further author information
,
Matheus Henrique dos Santosa Department of Cellular and Molecular Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao, Sao Paulo, BrazilView further author information
,
Júlia Garcia Guimarãesa Department of Cellular and Molecular Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao, Sao Paulo, BrazilView further author information
,
Gabriela Yamazaki de Camposa Department of Cellular and Molecular Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao, Sao Paulo, BrazilView further author information
,
Patrícia Kellen Martins Oliveira Britoa Department of Cellular and Molecular Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao, Sao Paulo, BrazilView further author information
,
Camilly Melo Garcia Ferreiraa Department of Cellular and Molecular Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao, Sao Paulo, BrazilView further author information
,
Caroline Patini Rezendeb Department of Biochemistry and Immunology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao, Sao Paulo, BrazilView further author information
,
Natália Fernandes Frotac Federal University of Ceara (UFC), Fortaleza, Ceara, BrazilView further author information
,
Sandro Gomes Soaresd Department of Biochemistry, University of Cambridge, Cambridge, UKView further author information
,
Pappanaicken R. Kumaresane Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Marcos Roberto Lourenzonif Fundação Oswaldo Cruz Ceará (Fiocruz-CE), Research Group on Protein Engineering and Health Solutions (GEPeSS), Eusébio, Ceara, BrazilView further author information
&
Thiago Aparecido da Silvaa Department of Cellular and Molecular Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao, Sao Paulo, Brazil;g Department of Clinical Analysis, School of Pharmaceutical Sciences in Araraquara, Sao Paulo State University, Araraquara, Sao Paulo, BrazilCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5017-6539View further author information
ORCID Icon show all
Article: 2281059 | Received 31 Aug 2023, Accepted 02 Nov 2023, Published online: 18 Nov 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.